# CORRESP — GALECTIN THERAPEUTICS INC  (GALT)  (CIK 0001133416)

> <strong>GALECTIN THERAPEUTICS INC  (GALT)  (CIK 0001133416) → SEC staff</strong> · filed 2026-04-08 · ticker GALT · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001140361-26-013760
- **Form:** CORRESP
- **Filer:** GALECTIN THERAPEUTICS INC  (GALT)  (CIK 0001133416)
- **CIK:** 0001133416
- **Ticker:** GALT
- **Filed:** 2026-04-08
- **SIC industry:** 2834
- **HQ:** Norcross, GA

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1133416/000114036126013760/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1133416&type=UPLOAD&dateb=&owner=include&count=40

## Other comment-letter activity for GALECTIN THERAPEUTICS INC  (GALT)  (CIK 0001133416)

- UPLOAD — 2026-04-06 — /comment-letter/0000000000-26-003426

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, GALECTIN THERAPEUTICS INC  (GALT)  (CIK 0001133416) (CIK 0001133416), filed 2026-04-08, accession 0001140361-26-013760. Retrieved via MORVS 2026-11-12 from https://api.morvs.ai/comment-letter/0001140361-26-013760.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*